SCHEMBL2864722

SCHEMBL2864722

CC(C)(C)OC(=O)n1nc(-c2cccc(F)c2)c2cc([N+](=O)[O-])ccc21

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.47
ELANE P08246 8/20 0.42
F2 P00734 4/20 0.42
PLAU P00749 4/20 0.42
CTRB1 P17538 4/20 0.42
KLKB1 P03952 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
F2RL3 Q96RI0 5/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
F2R P25116 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 1/20 0.38
ABCG2 Q9UNQ0 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4005625 0.89 L3MBTL1 (0.61) MAP2K4L3MBTL1ELANEF2PLAU
SCHEMBL2860687 0.84 L3MBTL1 (0.54) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL2860693 0.84 L3MBTL1 (0.54) L3MBTL1ELANEF2PLAUCTRB1
SCHEMBL2860870 0.84 MAP2K4 (0.61) MAP2K4ELANE
SCHEMBL2871097 0.82 MAP2K4 (0.56) MAP2K4ELANEMAPT
SCHEMBL2858091 0.82 MAP2K4 (0.56) MAP2K4ELANEMAPT
SCHEMBL13198131 0.81 MAP2K4 (0.55) MAP2K4ELANEMAPT
SCHEMBL2862273 0.81 MAP2K4 (0.55) MAP2K4ELANEMAPT
SCHEMBL2863260 0.81 MAP2K4 (0.58) MAP2K4ELANEMAPT
SCHEMBL6375106 0.81 L3MBTL1 (0.52) MAP2K4L3MBTL1ELANEF2PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885L3MBTL1 2399/4885ELANE 3796/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885L3MBTL1 3204/4885ELANE 4492/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885L3MBTL1 2399/4885ELANE 3796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.